Brady Corporation declares regular dividend to shareholders
Get Alerts BRC Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 1.6%
EPS Growth %: +10.5%
Join SI Premium – FREE
MILWAUKEE, Feb. 17, 2021 (GLOBE NEWSWIRE) -- On February 17, 2021, Brady Corporation’s (NYSE: BRC) Board of Directors declared a quarterly dividend to shareholders of the company's Class A Common Stock of $0.22 per share, payable on April 30, 2021, to shareholders of record at the close of business on April 9, 2021.
Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2020, employed approximately 5,400 people in its worldwide businesses. Brady’s fiscal 2020 sales were approximately $1.08 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradycorp.com/investors.
For More Information Contact:Investor Contact: Ann Thornton (414) 438-6887Media Contact: Kate Venne (414) 438-5176
Source: Brady Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, and Doximity Innovations and Encourages Investors to Contact the Firm
- LINCOLN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lincoln National Corporation and Encourages Investors to Contact the Firm
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!